MX2009011281A - Benzimidazol y composiciones farmaceuticas del mismo. - Google Patents
Benzimidazol y composiciones farmaceuticas del mismo.Info
- Publication number
- MX2009011281A MX2009011281A MX2009011281A MX2009011281A MX2009011281A MX 2009011281 A MX2009011281 A MX 2009011281A MX 2009011281 A MX2009011281 A MX 2009011281A MX 2009011281 A MX2009011281 A MX 2009011281A MX 2009011281 A MX2009011281 A MX 2009011281A
- Authority
- MX
- Mexico
- Prior art keywords
- benzimidazoles
- pharmaceutical compositions
- pharmaceutically acceptable
- relates
- patient
- Prior art date
Links
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000589601 Francisella Species 0.000 abstract 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91298007P | 2007-04-20 | 2007-04-20 | |
| PCT/US2008/005084 WO2008130669A1 (en) | 2007-04-20 | 2008-04-21 | Benzimidazoles and pharmaceutical compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009011281A true MX2009011281A (es) | 2010-03-08 |
Family
ID=39875833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009011281A MX2009011281A (es) | 2007-04-20 | 2008-04-21 | Benzimidazol y composiciones farmaceuticas del mismo. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8232410B2 (enExample) |
| EP (1) | EP2154966B1 (enExample) |
| JP (1) | JP5400032B2 (enExample) |
| CN (1) | CN101677553A (enExample) |
| AU (1) | AU2008242488B2 (enExample) |
| BR (1) | BRPI0810244A2 (enExample) |
| CA (1) | CA2684594C (enExample) |
| DK (1) | DK2154966T3 (enExample) |
| EA (1) | EA016726B1 (enExample) |
| ES (1) | ES2434693T3 (enExample) |
| HR (1) | HRP20131103T1 (enExample) |
| IN (1) | IN2009KN03959A (enExample) |
| MX (1) | MX2009011281A (enExample) |
| PL (1) | PL2154966T3 (enExample) |
| PT (1) | PT2154966E (enExample) |
| SI (1) | SI2154966T1 (enExample) |
| WO (1) | WO2008130669A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8232310B2 (en) | 2006-12-29 | 2012-07-31 | Georgetown University | Targeting of EWS-FLI1 as anti-tumor therapy |
| US8039502B2 (en) | 2007-07-24 | 2011-10-18 | The Ohio State University Research Foundation | Anti-infective agents against intracellular pathogens |
| US20120108823A1 (en) | 2009-04-22 | 2012-05-03 | The Ohio State University Research Foundation | Anti-francisella agents |
| CN102695546B (zh) | 2009-09-11 | 2014-09-10 | 前体生物药物股份公司 | 作为谷氨酰胺酰环化酶抑制剂的杂环衍生物 |
| WO2013116823A1 (en) * | 2012-02-02 | 2013-08-08 | The Research Foundation Of State University Of New York | Benzimidazoles and uses thereof |
| WO2013142326A1 (en) * | 2012-03-23 | 2013-09-26 | The Research Foundation Of State University Of New York | 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis |
| MX377618B (es) * | 2012-04-12 | 2025-03-07 | Univ Georgetown | Métodos y composiciones para el tratamiento de la familia de tumores del sarcoma de ewing. |
| CN103333170B (zh) * | 2013-06-14 | 2016-08-10 | 清华大学 | 苯并咪唑类化合物及其用途 |
| MX2016004678A (es) | 2013-10-24 | 2017-03-10 | Univ Georgetown | Composiciones para el tratamiento del cancer. |
| US9845296B2 (en) | 2013-11-22 | 2017-12-19 | The Research Foundation For The State University Of New York | Benzimidazoles and their use in the treatment of tuberculosis |
| WO2015138611A2 (en) | 2014-03-11 | 2015-09-17 | Colorado State University Research Foundation | Methods for improved in vitro-in vivo efficacy determination |
| US11279714B2 (en) * | 2014-06-20 | 2022-03-22 | Institut Pasteur Korea | Anti-infective compounds |
| EP3204376B1 (en) | 2014-10-09 | 2023-04-19 | Oncternal Therapeutics, Inc. | Indolinone compounds and uses thereof |
| EP3436434B1 (en) | 2016-03-31 | 2020-07-08 | Oncternal Therapeutics, Inc. | Indoline analogs and uses thereof |
| EP3490553B1 (en) | 2016-07-29 | 2024-08-28 | Oncternal Therapeutics, Inc. | Combination comprising an indolinone compound and its use in the treatment of lymphoma |
| CN111303092B (zh) * | 2020-04-07 | 2021-05-25 | 山东昌邑灶户盐化有限公司 | 2,4-二硝基-6-氯苯胺衍生物、合成方法及其应用 |
| CA3226162A1 (en) | 2021-07-09 | 2023-01-12 | Plexium, Inc. | Aryl compounds and pharmaceutical compositions that modulate ikzf2 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61170732A (ja) * | 1985-01-25 | 1986-08-01 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
| US7405235B2 (en) | 2001-05-04 | 2008-07-29 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
| JP4953456B2 (ja) * | 2004-09-30 | 2012-06-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）として有用な新規なベンゾイミダゾール誘導体 |
| WO2007105023A1 (en) * | 2006-03-15 | 2007-09-20 | Csir | Modulation of phosphoryl transferase activity of glutamine synthetase |
-
2008
- 2008-04-21 CA CA2684594A patent/CA2684594C/en active Active
- 2008-04-21 PT PT87998829T patent/PT2154966E/pt unknown
- 2008-04-21 CN CN200880021064A patent/CN101677553A/zh active Pending
- 2008-04-21 PL PL08799882T patent/PL2154966T3/pl unknown
- 2008-04-21 WO PCT/US2008/005084 patent/WO2008130669A1/en not_active Ceased
- 2008-04-21 AU AU2008242488A patent/AU2008242488B2/en not_active Ceased
- 2008-04-21 US US12/596,347 patent/US8232410B2/en not_active Expired - Fee Related
- 2008-04-21 BR BRPI0810244-9A patent/BRPI0810244A2/pt not_active Application Discontinuation
- 2008-04-21 ES ES08799882T patent/ES2434693T3/es active Active
- 2008-04-21 DK DK08799882.9T patent/DK2154966T3/da active
- 2008-04-21 IN IN3959KON2009 patent/IN2009KN03959A/en unknown
- 2008-04-21 MX MX2009011281A patent/MX2009011281A/es active IP Right Grant
- 2008-04-21 HR HRP20131103AT patent/HRP20131103T1/hr unknown
- 2008-04-21 EP EP08799882.9A patent/EP2154966B1/en not_active Not-in-force
- 2008-04-21 JP JP2010504113A patent/JP5400032B2/ja not_active Expired - Fee Related
- 2008-04-21 SI SI200831097T patent/SI2154966T1/sl unknown
- 2008-04-21 EA EA200901423A patent/EA016726B1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5400032B2 (ja) | 2014-01-29 |
| BRPI0810244A2 (pt) | 2014-09-30 |
| JP2010524947A (ja) | 2010-07-22 |
| DK2154966T3 (da) | 2013-11-18 |
| AU2008242488A1 (en) | 2008-10-30 |
| CN101677553A (zh) | 2010-03-24 |
| HRP20131103T1 (hr) | 2013-12-20 |
| PT2154966E (pt) | 2013-11-13 |
| EA200901423A1 (ru) | 2010-06-30 |
| WO2008130669A1 (en) | 2008-10-30 |
| ES2434693T3 (es) | 2013-12-17 |
| SI2154966T1 (sl) | 2014-02-28 |
| US8232410B2 (en) | 2012-07-31 |
| EP2154966A1 (en) | 2010-02-24 |
| EP2154966A4 (en) | 2010-12-15 |
| EA016726B1 (ru) | 2012-07-30 |
| CA2684594A1 (en) | 2008-10-30 |
| PL2154966T3 (pl) | 2014-03-31 |
| IN2009KN03959A (enExample) | 2015-08-28 |
| AU2008242488B2 (en) | 2014-10-30 |
| EP2154966B1 (en) | 2013-08-21 |
| US20100256203A1 (en) | 2010-10-07 |
| CA2684594C (en) | 2015-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009011281A (es) | Benzimidazol y composiciones farmaceuticas del mismo. | |
| CY1124117T1 (el) | Ετεροκυκλικες αλκυνυλοβενζολικες ενωσεις και ιατρικες συνθεσεις και χρησεις αυτων | |
| UA114726C2 (uk) | 1,4-дизаміщені аналоги піридазину та способи лікування пов'язаних з дефіцитом smn станів | |
| MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| EA201100971A1 (ru) | Производные пиримидининдола для лечения злокачественного новообразования | |
| CY1116989T1 (el) | C-28 αμινες c-3 τροποποιημενων παραγωγων βετουλινικου οξεος ως αναστολεις hiv ωριμανσης | |
| PH12014500386A1 (en) | Combination treatment for hepatitis c | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| UA107112C2 (uk) | Активатори розчинної гуанілатциклази | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| MY149731A (en) | Compounds | |
| UA106636C2 (uk) | Морфолінотіазоли як позитивні алостеричні модулятори альфа 7 | |
| MX2010008921A (es) | Derivados de oxazolidinona. | |
| MY152279A (en) | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | |
| MX2011008910A (es) | Derivados de azol sustituidos, composicion farmaceutica que comprende los derivados, y uso de los derivados para tratar enfermeda de parkinson. | |
| ECSP10010052A (es) | Formulaciones galenicas de alisquireno y valsartan | |
| UA103500C2 (uk) | Сульфоксимінзаміщені анілінопіримідинові похідні як cdk-інгібітори, їх одержання й застосування як лікарських засобів | |
| MX2012013879A (es) | Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas. | |
| TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
| MX2009010374A (es) | Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos. | |
| TNSN08369A1 (en) | Benzimidazole derivatives | |
| TN2014000060A1 (en) | Benzothiazolone compound | |
| UA109793C2 (uk) | Арилсульфонаміди для лікування захворювань центральної нервової системи (цнс) | |
| MX2009008176A (es) | Derivados de tetrahidro-naftaleno sustituidos con heterociclos, su preparacion y su uso como medicamentos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FG | Grant or registration |